These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15647216)

  • 1. Evidence, economics, and emphysema: Medicare's long journey with lung volume reduction surgery.
    Ramsey SD; Sullivan SD
    Health Aff (Millwood); 2005; 24(1):55-66. PubMed ID: 15647216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicare's national coverage decisions, 1999-2003: quality of evidence and review times.
    Neumann PJ; Divi N; Beinfeld MT; Levine BS; Keenan PS; Halpern EF; Gazelle GS
    Health Aff (Millwood); 2005; 24(1):243-54. PubMed ID: 15647237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bariatric surgery coverage decision: opportunities and limitations.
    Elmore BL; Phillips WT
    Healthc Financ Manage; 2006 Oct; 60(10):52-4. PubMed ID: 17040030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using clinical trials as a condition of coverage: lessons from the National Emphysema Treatment Trial.
    Carino T; Sheingold S; Tunis S
    Clin Trials; 2004 Feb; 1(1):108-14; discussion 115-21. PubMed ID: 16281466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CMS's landmark decision on CT colonography.
    Cash BD
    N Engl J Med; 2009 Sep; 361(13):1316; author reply 1317. PubMed ID: 19776418
    [No Abstract]   [Full Text] [Related]  

  • 6. Medicare's coverage of colorectal cancer drugs: a case study in evidence development and policy.
    Carino T; Williams RD; Colbert AM; Bridger P
    Health Aff (Millwood); 2006; 25(5):1231-9. PubMed ID: 16966718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. With bated breath. Though Medicare will begin reimbursing for surgery to aid some emphysema patients, questions remain over benefit, cost.
    Becker C
    Mod Healthc; 2003 Oct; 33(41):40-1. PubMed ID: 14584199
    [No Abstract]   [Full Text] [Related]  

  • 8. CMS's landmark decision on CT colonography--examining the relevant data.
    Dhruva SS; Phurrough SE; Salive ME; Redberg RF
    N Engl J Med; 2009 Jun; 360(26):2699-701. PubMed ID: 19474419
    [No Abstract]   [Full Text] [Related]  

  • 9. New National Emphysema Treatment Trial paradigm of Health Care Financing Administration-sponsored clinical research trials: advances and dilemmas.
    Brenner M; Jones B; Daneschvar HL; Triff S
    J Investig Med; 2002 Mar; 50(2):95-100. PubMed ID: 11928948
    [No Abstract]   [Full Text] [Related]  

  • 10. Coverage options for promising technologies: Medicare's 'coverage with evidence development'.
    Tunis SR; Pearson SD
    Health Aff (Millwood); 2006; 25(5):1218-30. PubMed ID: 16966717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variations between clinical trial participants and Medicare beneficiaries in evidence used for Medicare national coverage decisions.
    Dhruva SS; Redberg RF
    Arch Intern Med; 2008 Jan; 168(2):136-40. PubMed ID: 18227358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is CMS's requirement for age-specific clinical evidence before considering coverage for CT colonography reasonable and necessary?
    Allen B
    J Am Coll Radiol; 2009 Sep; 6(9):606-8. PubMed ID: 19720352
    [No Abstract]   [Full Text] [Related]  

  • 13. Medicare's national coverage decisions for technologies, 1999-2007.
    Neumann PJ; Kamae MS; Palmer JA
    Health Aff (Millwood); 2008; 27(6):1620-31. PubMed ID: 18997221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: "CMS's landmark decision on CT colonography": misguided and short-sighted: pay me now or pay me later.
    Friedman AC; Lance P
    J Am Coll Radiol; 2010; 7(2):159-60. PubMed ID: 20142095
    [No Abstract]   [Full Text] [Related]  

  • 15. Federal Agencies scrutinize lung surgery.
    Environ Health Perspect; 1996 Nov; 104(11):1146-7. PubMed ID: 8959398
    [No Abstract]   [Full Text] [Related]  

  • 16. Considering changes to CMS's national coverage decision process: applying lessons learned from FDA as a regulator of access to healthcare technology.
    Zalesky CD
    Food Drug Law J; 2002; 57(1):73-93. PubMed ID: 12118482
    [No Abstract]   [Full Text] [Related]  

  • 17. Medicare's revised clinical trial policy and clinical trial-related provisions of FDAAA: what is a sponsor to do?
    Dobbins K; Scanlan K
    Food Drug Law J; 2007; 62(4):695-708. PubMed ID: 18557226
    [No Abstract]   [Full Text] [Related]  

  • 18. Medicare's national coverage determinations in diagnostic radiology: examining evidence and setting limits.
    Otero HJ; Chambers JD; Bresnahan BW; Kamae MS; Yucel KE; Neumann PJ
    Acad Radiol; 2012 Sep; 19(9):1060-5. PubMed ID: 22748382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicare Part D: successes and continuing challenges. Impact of Medicare Part D on Massachusetts health programs and beneficiaries.
    Thomas CP; Sussman J; ;
    Issue Brief (Mass Health Policy Forum); 2007 May; (32):1-32. PubMed ID: 17546802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paying accurately for imaging services in medicare.
    Winter A; Ray N
    Health Aff (Millwood); 2008; 27(6):1479-90. PubMed ID: 18997203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.